Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02164409 · ClinicalTrials.gov registry record
Changes Associated With H. Pylori and Gastric Carcinogenesis
A clinical trial of Bacterial Infection Due to Helicobacter Pylori (H. Pylori), sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT02164409: Recruiting study of Bacterial Infection Due to Helicobacter Pylori (H. Pylori), sponsored by Weill Medical College of Cornell University.
NCT02164409 is a study of Bacterial Infection Due to Helicobacter Pylori (H. Pylori) that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 120 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02164409, a study of Bacterial Infection Due to Helicobacter Pylori (H. Pylori), is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study for patients who currently have or previously had an H. pylori infection or who have gastric or esophageal cancer and who plan to undergo an endoscopy as part of their care. The purpose of this study is to find out how and why H. pylori infections can cause progression to gastric cancer and if it's possible for intervention prior to this progression.
Primary Outcome
Ability to obtain adequate tissue for next generation sequencing from endoscopy
Conditions Studied
Interventions
- PROCEDURE Endoscopy tissue collection
Study Locations (1)
New York
- Weill Cornell Medical College - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2012-07 |
| Est. Completion | 2026-04 |
What NCT02164409 shows while recruiting
NCT02164409 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Bacterial Infection Due to Helicobacter Pylori (H. Pylori) appearing as the primary indexed condition, and to 1 intervention - of which Endoscopy tissue collection is the first listed.
NCT02164409 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02164409 about?
NCT02164409 is a clinical study titled "Changes Associated With H. Pylori and Gastric Carcinogenesis". This is a research study for patients who currently have or previously had an H. pylori infection or who have gastric or esophageal cancer and who plan to undergo an endoscopy as part of their care. The purpose of this study is to find out how and why H. pylori infections can cause progression to ga...
What is the current status of trial NCT02164409?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2012-07. Estimated completion is 2026-04.
What conditions does trial NCT02164409 study?
This clinical trial studies the following conditions: Bacterial Infection Due to Helicobacter Pylori (H. Pylori).
What interventions are being tested in trial NCT02164409?
The interventions under investigation include: Endoscopy tissue collection (PROCEDURE).
Who is sponsoring clinical trial NCT02164409?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02164409 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia